As we observe World Tuberculosis Day 2026 with the theme ‘Yes! We Can End TB: Led by countries, powered by people,’ it is crucial to recognize that systemic inefficiencies continue to hinder the fight against tuberculosis despite significant scientific advances.
A Historical Perspective and Modern Challenges
The haunting story of George Orwell, who battled tuberculosis while writing his dystopian classic 1984, underscores TB’s long-standing impact on the displaced and vulnerable. Orwell, born in Bihar and writing on a Scottish island in 1947, succumbed to the disease less than two years later. His struggle reminds us that TB has historically thrived among marginalized populations.
Today, we possess the tools to combat TB more effectively than Orwell could have imagined. Yet, the global narrative remains trapped in an outdated cycle, where technological breakthroughs are not matched by operational reforms. To truly end TB, health systems must move beyond a narrow clinical focus and address systemic failures that leave millions behind.
Scientific Progress vs. Systemic Failures
For decades, drug-resistant TB (DR-TB) was almost a death sentence, requiring 18 to 24 months of treatment with thousands of pills and painful injections, often resulting in permanent side effects. The introduction of the all-oral BPaLM regimen—comprising Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin—has revolutionized treatment, reducing recovery time to just six months.
However, clinical success does not equate to social success. Many patients who are cured still face loss of employment, social stigma, and marginalization. Ending TB requires addressing these social determinants alongside medical treatment.
Gender Disparities in TB Care
Men bear a disproportionate burden of TB, accounting for about 55% of cases globally, compared to 33% for women and 12% for children, according to the WHO. This imbalance is rooted in social norms that discourage men from seeking early care, fearing lost wages and stigma. To bridge this gap, health systems must adopt flexible, community-based approaches that reach men where they work, rather than relying solely on traditional clinic hours.
Fragmented Systems and the Need for Integration
Treating TB in isolation is an outdated approach. The disease often coexists with other conditions such as diabetes, malnutrition, and HIV—factors that exacerbate the disease’s impact. For example, people living with HIV are 16 times more likely to develop TB, while diabetes doubles or triples the risk.
Despite this, health systems remain siloed, forcing patients to navigate disconnected clinics. Integration of services—combining TB, HIV, diabetes, and nutritional care—is essential to treat the whole person effectively.
The Human Cost and a Call to Action
Ending TB requires more than scientific innovation; it demands leadership and systemic reform. The high human cost of TB cure is rooted not in medicine’s efficacy but in the failures of health systems to deliver that medicine equitably and holistically.
As we mark World Tuberculosis Day, let us renew our commitments and hold our health systems accountable—because the fight against TB is a fight for social justice, equity, and human dignity.
